On the Capex front, the company has invested Rs. 416 crore in the first half and it is broadly in line with our guidance for the two years around Rs. 2,000 crore across all the subsidiaries and divisions
The centres will be located in Tier I and Tier II cities
Partners with GITAM University to train 27 employees through a 10-day HR module and make them future-ready
Brazil has the 4th largest pet market in the world with an estimated market size of BRL 1.8 billion, growing annually at 16%
Intox is a GLP certified pre-clinical contract research organization with its test facilities in Pune
Solara Active Pharma Sciences has reported consolidated financial results for the period ended September 30, 2021.
This robust performance is a testimony of the company's agility, resilience and strong execution capabilities during these difficult times
India is dependent upon China and other countries for a lot of Key Starting Materials (KSM) for their bulk drug needs.
The company has an outlay of Rs 120-140 crore as R & D expense for FY 22
The company has already embarked upon significant expansion in Turkey
Subscribe To Our Newsletter & Stay Updated
_256_275.jpeg)
